Eosinophilia/myalgia syndrome associated with L-tryptophan
β Scribed by Pfanner, TimothyP.; Person, DonaldA.; Berenberg, JeffreyL.; Gayle, EverettL.; Lockett, L.John; Schwartzberg, Mori; Weber, CharlesA.; Graybiel, AshtonL.; Harris, DianaC.; Orth, RuthW.
- Book ID
- 122890826
- Publisher
- The Lancet
- Year
- 1990
- Tongue
- English
- Weight
- 488 KB
- Volume
- 335
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The clinical constellation of leukocytosis, thrombocytosis, and low or absent stainable neutrophil alkaline phosphatase (NAP) is considered characteristic of chronic myelogenous leukemia (CML) [l]. CML with eosinophilic differentiation (eosinophilic leukemia) is well described [2], and leukemia and
physicians in New Mexico notified the New Mexico Department of Health and Environment of 3 patients with marked eosinophilia and severe. incapacitating myalgia who had been taking the amino acid L-tryptophan (orally) and whose illness, after thorough clinical evaluation, seemed both unusual and obsc